Clovis Oncology Inc (CLVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLVS | BCLI | IMRN | ||
| Company | Clovis Oncology Inc | Brainstorm Cell | Immuron Ltd ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.0808 | 2.23 | 1.9700 | ||
| High | 0.0977 | 2.45 | 2.0150 | ||
| Low | 0.0766 | 2.20 | 1.8600 | ||
| Last | 0.0812 | 2.28 | 1.9600 | ||
| Change | -0.0048 | +0.20 | -0.0350 | ||
| % Change | -5.58% | +9.62% | -1.75% | ||
| Volume | 24,516,400 | 197,800 | 4,400 | ||
| 20-Day Average Volume | 9,433,500 | 127,185 | 5,975 | ||
| Previous Close | 0.0860 | 2.08 | 1.9950 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.2340 | 1.68 | 2.0101 | ||
| 20-Day Raw Stochastic | 1.73% | 86.30% | 29.69% | ||
| 20-Day Relative Strength | 23.83% | 60.27% | 46.39% | ||
| Weighted Alpha | -91.19 | -67.11 | -41.25 | ||
| Today's Opinion | 100% Sell | 56% Sell | 72% Sell | ||
| Previous Opinion | 100% Sell | 56% Sell | 56% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -39.04% since 12/13/22 | +57.24% since 12/13/24 | -7.78% since 12/13/24 | ||
| Low | 0.0760 on 12/16/22 | 1.42 on 12/16/24 | 1.8600 on 12/20/24 | ||
| High | 0.1439 on 12/14/22 | 2.45 on 12/20/24 | 2.2250 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | -76.74% since 11/18/22 | +80.95% since 11/20/24 | +3.79% since 11/20/24 | ||
| Low | 0.0760 on 12/16/22 | 1.21 on 11/22/24 | 1.7700 on 12/03/24 | ||
| High | 0.3772 on 12/01/22 | 2.45 on 12/20/24 | 2.4100 on 12/10/24 | ||
| 3-Month | |||||
| %Chg | -92.75% since 09/20/22 | -37.40% since 09/20/24 | -21.91% since 09/20/24 | ||
| Low | 0.0760 on 12/16/22 | 1.05 on 11/14/24 | 1.7334 on 11/13/24 | ||
| High | 1.3100 on 10/04/22 | 3.96 on 09/24/24 | 2.8670 on 10/01/24 | ||
| 6-Month | |||||
| %Chg | -93.12% since 06/17/22 | -60.67% since 06/20/24 | -8.84% since 06/20/24 | ||
| Low | 0.0760 on 12/16/22 | 1.05 on 11/14/24 | 1.7334 on 11/13/24 | ||
| High | 3.2500 on 07/08/22 | 6.60 on 06/26/24 | 2.8700 on 09/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,770 | 13,004 | 11,228 | ||
| Shares Outstanding, K | 144,955 | 5,703 | 5,729 | ||
| Annual Sales | 148,760,000 | 0 | 3,220,000 | ||
| Annual Net Income | -264,520,000 | -17,190,000 | -4,550,000 | ||
| Last Quarter Sales | 30,660,000 | 0 | N/A | ||
| Last Quarter Net Income | -56,010,000 | -2,710,000 | N/A | ||
| 60-Month Beta | 0.24 | 0.36 | 1.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/09/22 | -1.80 on 11/14/24 | N/A | ||
| Latest Earnings Date | 11/09/22 | 11/12/24 | 10/02/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||